PortfoliosLab logo

Remegen Co Ltd (9995.HK)

Equity · Currency in HKD · Last updated Jun 3, 2023

Company Info

ISINCNE1000048G6
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$29.81B
EPS-HK$2.19
PE RatioN/A
PEG RatioN/A
Revenue (TTM)HK$785.88M
Gross Profit (TTM)HK$794.11M
EBITDA (TTM)-HK$1.14B
Year RangeHK$29.60 - HK$74.80
Target PriceHK$67.80

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in Remegen Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%2023FebruaryMarchAprilMayJune
-36.07%
6.19%
9995.HK (Remegen Co Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 9995.HK

Remegen Co Ltd

Return

Remegen Co Ltd had a return of -44.91% year-to-date (YTD) and 7.59% in the last 12 months. Over the past 10 years, Remegen Co Ltd had an annualized return of -26.85%, while the S&P 500 had an annualized return of 4.85%, indicating that Remegen Co Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-28.48%3.19%
Year-To-Date-44.91%9.50%
6 months-32.84%4.00%
1 year7.59%-2.77%
5 years (annualized)-26.85%4.85%
10 years (annualized)-26.85%4.85%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20238.81%-18.41%-18.58%9.44%-26.09%
20220.10%17.09%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Remegen Co Ltd (9995.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
9995.HK
Remegen Co Ltd
0.25
^GSPC
S&P 500
0.21

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Remegen Co Ltd Sharpe ratio is 0.25. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.502023FebruaryMarchAprilMayJune
0.25
0.10
9995.HK (Remegen Co Ltd)
Benchmark (^GSPC)

Dividend History


Remegen Co Ltd doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%2023FebruaryMarchAprilMayJune
-77.85%
-10.56%
9995.HK (Remegen Co Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Remegen Co Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Remegen Co Ltd is 81.94%, recorded on May 10, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.94%Feb 17, 2021301May 10, 2022
-15.58%Jan 21, 20216Jan 28, 20218Feb 9, 202114
-15.15%Nov 17, 202014Dec 4, 202011Dec 21, 202025
-11.34%Jan 12, 20214Jan 15, 20213Jan 20, 20217
-6.02%Nov 10, 20202Nov 11, 20201Nov 12, 20203

Volatility Chart

The current Remegen Co Ltd volatility is 11.29%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%2023FebruaryMarchAprilMayJune
11.29%
3.64%
9995.HK (Remegen Co Ltd)
Benchmark (^GSPC)